Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

Most stocks are down for the past month, making this ticker’s recent gains even more impressive. Warren Buffett’s December addition of this stock to an existing position may have sparked what ...

First off, Monsterpatch has two versions (Skyfarer and Aurora), each with their own antagonists and version-exclusive ...

The fourth installment in the Monsterverse, following 2014’s “Godzilla’ and its 2019 sequel as well as 2019’s “Kong: Skull Island,” this monster mash-up is enjoyable popcorn entertainment.